Abatement in US pricing pressure and broad-based growth across markets lead to stable growth during H1FY2020; regulatory overhang in the form of recurring issuances of Warning Letters remains concern
Please click here to Register Now
Indian Pharmaceuticals Sector – Key Trends and Outlook
22nd January, 2020 at 4.30 PM (IST)
Discussion Agenda:
  • Key Trends in Financial Performance
  • Performance across Key Geographies – USA, India, Europe and Emerging Markets
  • Outlook for FY 2021
Mr. Subrata Ray Mr. Subrata Ray
Senior Group Vice President
ICRA Limited
Mr. Gaurav Jain Mr. Gaurav Jain
Vice President
ICRA Limited
Ms. Kinjal Shah Ms. Kinjal Shah
Vice President
ICRA Limited
ICRA events